Vectus Biosystems Ltd (VBS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.572x

Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has a cash flow conversion efficiency ratio of 2.572x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-659.98K ≈ $-466.98K USD) by net assets (AU$-256.62K ≈ $-181.58K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see VBS market cap for the company's overall valuation and market capitalisation.

Vectus Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Vectus Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vectus Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vectus Biosystems Ltd ranked by their cash flow conversion efficiency. See VBS operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Erika Carmel-Tech Ltd TA:ERKA	-0.383x
Gulf Keystone Petroleum Ltd LSE:GKP	0.040x
Adneo Ltd AU:AD1	0.522x
Mantle Minerals Ltd AU:MTL	-0.118x
Optima Prima Metal Sinergi JK:OPMS	-0.014x
GEOTRANS S.A. ZY -10 F:5Z4	-0.016x
PZ Cussons PLC LSE:PZC	0.034x
Foresight Autonomous Holdings Ltd ADR NASDAQ:FRSX	-0.464x

Annual Cash Flow Conversion Efficiency for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Vectus Biosystems Ltd from 2012 to 2025. View VBS stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-256.62K ≈ $-181.58K	AU$-830.09K ≈ $-587.34K	3.235x	+336.52%
2024-06-30	AU$1.49 Million ≈ $1.05 Million	AU$-2.03 Million ≈ $-1.44 Million	-1.368x	-104.82%
2023-06-30	AU$3.52 Million ≈ $2.49 Million	AU$-2.35 Million ≈ $-1.66 Million	-0.668x	-166.48%
2022-06-30	AU$-4.42 Million ≈ $-3.13 Million	AU$-4.44 Million ≈ $-3.14 Million	1.004x	-10.54%
2021-06-30	AU$-2.90 Million ≈ $-2.05 Million	AU$-3.26 Million ≈ $-2.30 Million	1.123x	+151.03%
2020-06-30	AU$-6.71 Million ≈ $-4.75 Million	AU$-3.00 Million ≈ $-2.12 Million	0.447x	+60.32%
2019-06-30	AU$-3.73 Million ≈ $-2.64 Million	AU$-1.04 Million ≈ $-736.30K	0.279x	-54.62%
2018-06-30	AU$-2.26 Million ≈ $-1.60 Million	AU$-1.39 Million ≈ $-981.46K	0.615x	+101.84%
2017-06-30	AU$116.56K ≈ $82.48K	AU$-3.89 Million ≈ $-2.75 Million	-33.399x	-4696.01%
2016-06-30	AU$3.75 Million ≈ $2.65 Million	AU$-2.61 Million ≈ $-1.85 Million	-0.696x	-376.09%
2015-06-30	AU$11.22 Million ≈ $7.94 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.146x	+99.37%
2014-06-30	AU$55.53K ≈ $39.29K	AU$-1.29 Million ≈ $-915.18K	-23.292x	-1926.15%
2013-06-30	AU$976.04K ≈ $690.61K	AU$-1.12 Million ≈ $-793.92K	-1.150x	-141.21%
2012-06-30	AU$-504.57K ≈ $-357.02K	AU$-1.41 Million ≈ $-995.86K	2.789x	--

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$5.10 Million

AU$7.21 Million AUD

Market Cap Rank

#28645 Global

#1532 in Australia

Share Price

AU$0.14

Change (1 day)

+0.00%

52-Week Range

AU$0.06 - AU$0.44

All Time High

AU$2.00